CORT Dividend History & Analysis | N/A Yield
CORT has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Pharmaceuticals
| Symbol | Market Cap (USD) | Dividend Yield TTM | Yield on Cost (purchase 5y ago) |
|---|---|---|---|
| SIGA | 593 M | 9.17% | 11.4% |
| PFE | 138,102 M | 7.04% | 5.90% |
| OGN | 1,755 M | 8.85% | 2.20% |
| PRGO | 2,853 M | 7.94% | 2.93% |
| BMY | 93,773 M | 5.31% | 4.70% |
| Symbol | Market Cap (USD) | Growth Rate (CAGR) | Payout Consistency |
|---|---|---|---|
| RPRX | 21,892 M | 29.4% | 100% |
| ZTS | 63,858 M | 21.2% | 100% |
| LLY | 772,276 M | 15.1% | 99.5% |
| SIGA | 593 M | 15.5% | 98.8% |
| RDY | 11,250 M | 28.0% | 87.3% |
Similar Stocks with Attractive Dividends - Compare CORT Dividends with its Peer-Group
9.17% Yield
3.76% Yield
3.69% Yield
4.59% Yield
3.42% Yield
3.16% Yield
CORT Dividend History: as of November 2025
No dividends paid yet.CORT Dividend FAQ
Corcept Therapeutics (NASDAQ:CORT) is a U.S.-based biopharma focused on developing and commercializing medicines for severe endocrine-related disorders. Its only FDA-approved product, Korlym (mifepristone), treats hyperglycemia secondary to endogenous Cushing’s syndrome in adults who are ineligible for or have failed surgery. The pipeline spans multiple phases: relacorilant is in Phase III for hypercortisolism and in a separate Phase III trial combined with nab-paclitaxel for platinum-resistant ovarian cancer; early-stage programs target adrenal cancer, prostate cancer, ALS (dazucorilant, Phase II), and metabolic-dysfunction-associated steatohepatitis (miricorilant, Phase IIb).
What is the Dividend Yield of CORT?
As of November 2025, CORT`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 73.72.Does CORT pay a dividend?
As of November 2025 CORT does not pay a dividend.How often does CORT pay dividends?
Over the last 12 months, CORT has issued dividend payments.Will CORT pay dividends in 2025?
The next Ex-Dividend date for Corcept Therapeutics (CORT) is currently unknown.What is the next Ex-Dividend Date for CORT?
The next Ex-Dividend date for Corcept Therapeutics (CORT) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.What is the Dividend Growth of CORT?
CORT's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of CORT?
CORT's 5-Year Yield on Cost is -%. If you bought CORT's shares at 17.94 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.What is the Payout Consistency of CORT?
CORT Payout Consistency is 0.0%.
The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Does CORT have a good Dividend Yield?
CORT`s % Dividend Yield is considered as unknown.What is the Dividend Payout Ratio of CORT?
The Dividend Payout Ratio of CORT is unknown.What is the Dividend Rating of CORT?
CORT`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.Key Metric Definitions
- Dividend Yield: Annual dividend per share divided by current share price.
- Dividend Growth Rate: Compound annual growth rate of annual dividend per share over the last 5 years.
- Payout Ratio: Percentage of earnings paid as dividends (TTM).
- Payout Consistency: % of eligible periods with uninterrupted or increased dividends, measured over the entire lifetime of the stock or fund.
- Payout Frequency: Number of dividends paid in the last 12m (TTM).
- Overall Dividend Rating: Proprietary composite score, quantified on a scale from 0 to +100. Ratings surpassing 70 are regarded as favorable, while those exceeding 85 are strong.
- Total Return: Price appreciation plus dividends over specified period.
- Market Cap: Figures are in millions of the corresponding currency.
Last update: 2025-10-27 02:01